Скачать или смотреть EDSA Stock: A Huge 52-Week Low Rebound. Edesa Biotech Inc-EDSA.

Investors are responding positively to the company announcing positive results from the Phase 2 part of an ongoing Phase 2/3 clinical study evaluating the company’s monoclonal antibody candidate, designated EB05, as a single-dose treatment for hospitalized COVID-19 patients.--https://pulse2.com/edesa-biotech-nasd...


As of 11:53 AM ET Monday, 09/20/2021 EDSA appeared to be in a strong bullish trend. Its 200-day moving average is upwards sloping and the MACD histogram is above 0. Comparative Relative Strength analysis shows that this issue is outperforming the S&P 500.


edsa stock buy or sell
edsa stock news
edsa stock forecast
edsa stocktwits
edesa biotech
edsa stock price target
edsa stock discussion
edsa stock tsx